Cite
HARVARD Citation
van der Heijde, D. et al. (n.d.). OP0170 Achieving ASDAS-CRP major improvement and inactive disease in patients with ankylosing spondylitis after treatment with golimumab is associated with normalized health related quality of life: Two-year results from the go-raise trial. Annals of the rheumatic diseases. p. 112. [Online].